Ceftazidime and Proventil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftazidime (ceftazidime) and Proventil (albuterol). Common drug interactions include infective pulmonary exacerbation of cystic fibrosis among females and disseminated intravascular coagulation among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftazidime and Proventil. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

What is Proventil?

Proventil has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 16,110 Proventil users. Check the latest studies of Proventil.



On Jul, 26, 2026

17 people who take Ceftazidime and Proventil together, and have interactions are studied.

Ceftazidime and Proventil drug interactions.

What are the common drug interactions of Ceftazidime and Proventil, by gender? *:

female:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Injection site pruritus (severe itching at injection site)
  4. Injection site swelling
  5. Oesophageal disorder (disease of oesophagus)
  6. Weight increased
  7. Alopecia (absence of hair from areas of the body)
  8. Anxiety
  9. Bronchopulmonary aspergillosis allergic (allergic lung disorder caused by aspergillus fungi)
  10. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)

male:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Gastrointestinal necrosis (destruction of gastrointestinal organ)
  4. Renal tubular necrosis (death of kidney tubules)
  5. Drug ineffective
  6. Drug intolerance (drug sensitivity)
  7. Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
  8. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  9. Peritoneal haemorrhage (peritoneal bleeding)
  10. Pulmonary haemorrhage (acute bleeding from the lung)

What are the common drug interactions of Ceftazidime and Proventil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Septic shock (shock due to blood infection)
  4. Cardiogenic shock (inadequate circulation of blood)
  5. Hepatic failure (liver failure)
  6. Hypotension (abnormally low blood pressure)
  7. Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
  8. Lactic acidosis (low ph in body tissues)
  9. Renal failure (kidney dysfunction)
  10. Status asthmaticus (a asthma attack not responds to regular medicines)

20-29:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Alopecia (absence of hair from areas of the body)
  2. Anxiety
  3. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  4. Increased appetite
  5. Insomnia (sleeplessness)
  6. Iron deficiency anaemia
  7. Nasal inflammation (inflammation of nose)
  8. Nasal septum perforation (hole in nasal septum)
  9. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  10. Weight increased

What are the existing conditions these people have? *

  1. Fever: 7 people, 41.18%
  2. Cystic Fibrosis (disease of the secretary glands): 6 people, 35.29%
  3. Immunodeficiency Common Variable: 3 people, 17.65%
  4. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 11.76%
  5. Indigestion: 2 people, 11.76%
  6. Sinusitis (inflammation of sinus): 2 people, 11.76%
  7. Cystic Fibrosis Related Diabetes: 1 person, 5.88%
  8. Back Pain: 1 person, 5.88%
  9. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 5.88%
  10. Constipation: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and Proventil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ceftazidime and Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftazidime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proventil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime and albuterol (the active ingredients of Ceftazidime and Proventil, respectively), and Ceftazidime and Proventil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: